Evidence map›Paper›PMID 34202756›Full record

ArticleJournal of fungi (Basel, Switzerland)2021

Inducible Selectable Marker Genes to Improve

Clara Baldin, Alexander Kühbacher, Petra Merschak, Luis Enrique Sastré-Velásquez, Beate Abt, Anna-Maria Dietl, Hubertus Haas, Fabio Gsaller

Open access · greenAbstract read
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Shining a light on the impact of antifungals onAntimicrobial agents and chemotherapy · 2024
    Article
  5. Article
  6. Characterization and engineering of the xylose-inducibleMetabolic engineering communications · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Clara BaldinInstitute of Molecular Biology, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-3895-9511
Alexander KühbacherInstitute of Molecular Biology, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Petra MerschakInstitute of Molecular Biology, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Luis Enrique Sastré-VelásquezInstitute of Molecular Biology, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Beate AbtInstitute of Molecular Biology, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Anna-Maria DietlInstitute of Molecular Biology, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Hubertus HaasInstitute of Molecular Biology, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0003-2472-9878
Fabio GsallerInstitute of Molecular Biology, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-9257-8648
Innsbruck Medical University · ATUniversität Innsbruck · AT

Funding

Austrian Science Fund FWF P 31093
6 · The paper itself

Abstract

The hygromycin B phosphotransferase gene from

Indexed as

Aspergillus fumigatusdominant selectable markerhphhygromycininducible markerptrApyrithiaminethiaminexylanase promoter

Identifiers

PMID34202756
PMCPMC8305790
OpenAlexW3175873038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.